Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Prostatic Hyperplasia × Urination × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Colorectal Neoplasms 2 Acute Kidney Injury 2 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Smoldering Multiple Myeloma 1 Salivary Gland Adenoma, Pleomorphic 1 Renal Insufficiency 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Disease 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dutasteride 2 Blood Specimen Collection 2 Urination 1 Transurethral Resection of Prostate 1 Therapeutics 1 Radiotherapy 1 Prostatectomy 1 Prostate-Specific Antigen 1 Magnetic Resonance Spectroscopy 1 Adrenergic alpha-Antagonists 1 5-alpha Reductase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116851 2023-11-03

PROMIC

Turku University Hospital

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡